The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Frequently Asked Questions about HIV Testing (3/19/19)
- Topics, Trends, and Updates (3/7/19)
- Updated Treatment of Chronic HCV with Direct-Acting Antivirals Guideline (2/21/19)
- Updated Pocket Guide to Selecting an Initial ART Regimen (2/5/19)
- Updated Selecting an Initial ART Regimen Guideline (1/28/19)
- New: When to Initiate ART Pocket Guide (12/21/18)
- Medscape Commentary: Preventing HPV in Patients With HIV: New Guidelines (10/26/18)
- New: HIV Testing Pocket Guide (10/8/18)
- AETC NCRC Updates (3/18/19)
- AIDSinfo: Updates Consumer Fact Sheets on HIV Treatment (3/14/19)
- NYC Health Advisory: Risk factors that contributed to HIV outbreaks in Massachusetts are present in New York City (3/1/19)
- AIDSinfo: Updated Consumer Fact Sheets on Living with HIV (2/28/19)
- Updates to the Disseminated Mycobacterium Avium Complex Disease Section of the Adult & Adolescent Opportunistic Infections Guidelines (2/15/19)
Performance of the ACC/AHA CVD Risk Calculator Among People With HIV: In December 2018, researchers reported their evaluation of the utility of 2 guidelines for statin use in predicting subsequent cardiovascular disease... Read more
Real-World, Event-Based PrEP at a Clinic in France: Pre-exposure prophylaxis (PrEP) is effective and important for HIV prevention among individuals at higher risk of HIV acquisition. Read more
- 2019 AIDS Institute Director Call to Action Letter (3/14/19)
- CEI Newsletter (3/12/19)
- NYS Medicaid Update (3/8/19)
- NYSDOH Position Statement: Expedited Partner Therapy to Treat Persons Exposed to Chlamydia (2/21/19)
- Implementing Transmucosal Buprenorphine for Treatment of Opioid Use Disorder: Joint Letter from NYS OASAS and NYS DOH (2/21/19)
- 3/27/19: CQII: Training of Coaching Basics Session (Dallas, TX)
- 3/30/19: CEI/Mount Sinai: From Stigma to Action: Addressing Substance Use, Harm Reduction & Healthcare (Hauppauge, NY)
- 4/01/19: CEI/Mount Sinai: 2 Day Transgender-Affirming Care Intensive Preceptorship (New York, NY)
- 4/04/19: HIV & Hepatitis in the Americas 2019 (Bogotá, Columbia)
- 4/05/19: NECA AETC/AMC: CROI 2019 Update: Report from the 2019 Conference on Retroviruses & Opportunistic Infection (Albany, NY)